SEI Investments’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$133M Buy
2,199,004
+166,705
+8% +$9.72M 0.12% 173
2025
Q4
$110M Buy
2,032,299
+1,071,564
+112% +$51.5M 0.11% 191
2025
Q3
$43.3M Buy
960,735
+156,256
+19% +$7.3M 0.05% 413
2025
Q2
$37.2M Buy
804,479
+48,725
+6% +$2.39M 0.04% 448
2025
Q1
$46.1M Buy
755,754
+88,595
+13% +$5.16M 0.06% 347
2024
Q4
$37.7M Sell
667,159
-177,308
-21% -$9.91M 0.05% 411
2024
Q3
$43.7M Buy
844,467
+157,775
+23% +$7.4M 0.06% 355
2024
Q2
$28.5M Sell
686,692
-135,546
-16% -$6.07M 0.04% 456
2024
Q1
$44.6M Buy
822,238
+172,775
+27% +$8.8M 0.07% 326
2023
Q4
$33.3M Sell
649,463
-963
-0.1% -$50.5K 0.05% 385
2023
Q3
$37.7M Sell
650,426
-21,748
-3% -$1.33M 0.07% 306
2023
Q2
$43M Sell
672,174
-2,509
-0.4% -$168K 0.08% 272
2023
Q1
$46.8M Buy
674,683
+101,913
+18% +$7.19M 0.09% 248
2022
Q4
$41.2M Sell
572,770
-41,993
-7% -$3.17M 0.09% 239
2022
Q3
$43.7M Buy
614,763
+12,001
+2% +$871K 0.1% 219
2022
Q2
$46.4M Buy
602,762
+135,678
+29% +$10.3M 0.1% 201
2022
Q1
$34.1M Buy
467,084
+15,573
+3% +$1.05M 0.07% 307
2021
Q4
$28.1M Buy
451,511
+4,636
+1% +$272K 0.05% 368
2021
Q3
$26.4M Sell
446,875
-13,784
-3% -$908K 0.06% 359
2021
Q2
$30.8M Sell
460,659
-18,476
-4% -$1.2M 0.07% 280
2021
Q1
$29.9M Sell
479,135
-40,814
-8% -$2.54M 0.08% 261
2020
Q4
$32.2M Sell
519,949
-1,213
-0.2% -$74.6K 0.08% 233
2020
Q3
$31.4M Sell
521,162
-114,233
-18% -$6.88M 0.09% 205
2020
Q2
$37.4M Sell
635,395
-58,711
-8% -$3.51M 0.12% 159
2020
Q1
$38.7M Buy
694,106
+22,866
+3% +$1.4M 0.14% 128
2019
Q4
$43.1M Buy
671,240
+127,030
+23% +$7.28M 0.13% 145
2019
Q3
$74.5M Buy
544,210
+45,024
+9% +$2.12M 0.19% 87
2019
Q2
$22.7M Sell
499,186
-70,803
-12% -$3.3M 0.07% 275
2019
Q1
$27.2M Sell
569,989
-387,615
-40% -$19.3M 0.09% 220
2018
Q4
$58.2M Buy
957,604
+113,696
+13% +$6.11M 0.21% 86
2018
Q3
$52.4M Buy
843,908
+360,807
+75% +$21.4M 0.19% 92
2018
Q2
$26.7M Buy
483,101
+13,612
+3% +$735K 0.09% 216
2018
Q1
$29.7M Sell
469,489
-77,898
-14% -$5.01M 0.11% 175
2017
Q4
$33.5M Sell
547,387
-34,371
-6% -$2.15M 0.12% 170
2017
Q3
$37.1M Sell
581,758
-83,815
-13% -$4.89M 0.13% 150
2017
Q2
$37.1M Buy
665,573
+8,890
+1% +$484K 0.15% 140
2017
Q1
$35.7M Sell
656,683
-84,040
-11% -$4.61M 0.16% 140
2016
Q4
$43.3M Buy
740,723
+65,407
+10% +$3.58M 0.21% 103
2016
Q3
$36.4M Sell
675,316
-265,089
-28% -$17M 0.19% 122
2016
Q2
$69.2M Buy
940,405
+24,044
+3% +$1.7M 0.41% 35
2016
Q1
$58.5M Sell
916,361
-62,194
-6% -$3.92M 0.36% 49
2015
Q4
$67.3M Buy
978,555
+284,571
+41% +$18.8M 0.41% 36
2015
Q3
$41.1M Buy
693,984
+349,398
+101% +$22.2M 0.38% 47
2015
Q2
$22.9M Buy
344,586
+46,886
+16% +$3.09M 0.21% 118
2015
Q1
$19.2M Sell
297,700
-11,507
-4% -$720K 0.17% 148
2014
Q4
$18.2M Buy
+309,207
New +$17.4M 0.16% 162

Other funds holding BMY

SEI Investments's BMY Position: Q1 2026 in Review

SEI Investments increased its Bristol-Myers Squibb (BMY) stake by 8.2% in Q1 2026, buying an estimated $9.72M and bringing the position to 2,199,004 shares worth $133M. The position accounts for 0.12% of the portfolio, ranked #173.

SEI Investments first reported a position in BMY in Q4 2014 and has held it in 46 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • SEI Investments held 2,199,004 shares of Bristol-Myers Squibb worth $133M as of Q1 2026.
  • SEI Investments bought 166,705 Bristol-Myers Squibb shares in Q1 2026, an estimated $9.72M.
  • Bristol-Myers Squibb made up 0.12% of SEI Investments's portfolio in Q1 2026, its #173 holding.
  • SEI Investments first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 46 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.